• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胞苷脱氨酶CEM15可诱导新合成的HIV-1 DNA发生超突变。

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

作者信息

Zhang Hui, Yang Bin, Pomerantz Roger J, Zhang Chune, Arunachalam Shyamala C, Gao Ling

机构信息

The Dorrance H. Hamilton Laboratories, Center for Human Virology and Biodefense, Division of Infectious Diseases and Environmental Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

出版信息

Nature. 2003 Jul 3;424(6944):94-8. doi: 10.1038/nature01707. Epub 2003 May 28.

DOI:10.1038/nature01707
PMID:12808465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1350966/
Abstract

High mutation frequency during reverse transcription has a principal role in the genetic variation of primate lentiviral populations. It is the main driving force for the generation of drug resistance and the escape from immune surveillance. G to A hypermutation is one of the characteristics of primate lentiviruses, as well as other retroviruses, during replication in vivo and in cell culture. The molecular mechanisms of this process, however, remain to be clarified. Here, we demonstrate that CEM15 (also known as apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; APOBEC3G), an endogenous inhibitor of human immunodeficiency virus type 1 (HIV-1) replication, is a cytidine deaminase and is able to induce G to A hypermutation in newly synthesized viral DNA. This effect can be counteracted by the HIV-1 virion infectivity factor (Vif). It seems that this viral DNA mutator is a viral defence mechanism in host cells that may induce either lethal hypermutation or instability of the incoming nascent viral reverse transcripts, which could account for the Vif-defective phenotype. Importantly, the accumulation of CEM15-mediated non-lethal hypermutation in the replicating viral genome could potently contribute to the genetic variation of primate lentiviral populations.

摘要

逆转录过程中的高突变频率在灵长类慢病毒群体的遗传变异中起主要作用。它是产生耐药性和逃避免疫监视的主要驱动力。G到A的超突变是灵长类慢病毒以及其他逆转录病毒在体内和细胞培养中复制时的特征之一。然而,这一过程的分子机制仍有待阐明。在此,我们证明CEM15(也称为载脂蛋白B mRNA编辑酶,催化多肽样3G;APOBEC3G),一种人类免疫缺陷病毒1型(HIV-1)复制的内源性抑制剂,是一种胞苷脱氨酶,能够在新合成的病毒DNA中诱导G到A的超突变。这种效应可被HIV-1病毒体感染性因子(Vif)抵消。看来这种病毒DNA诱变剂是宿主细胞中的一种病毒防御机制,可能诱导致命的超突变或进入的新生病毒逆转录产物的不稳定性,这可以解释Vif缺陷表型。重要的是,CEM15介导的非致命性超突变在复制的病毒基因组中的积累可能有力地促进灵长类慢病毒群体的遗传变异。

相似文献

1
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.胞苷脱氨酶CEM15可诱导新合成的HIV-1 DNA发生超突变。
Nature. 2003 Jul 3;424(6944):94-8. doi: 10.1038/nature01707. Epub 2003 May 28.
2
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.人类载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)通过对新生逆转录产物进行致死性编辑实现广泛的抗逆转录病毒防御。
Nature. 2003 Jul 3;424(6944):99-103. doi: 10.1038/nature01709. Epub 2003 May 28.
3
Good to CU.很高兴见到你。(注:原句“Good to CU.”表述有误,正确的应该是“Good to see you.”,这里按照正确内容翻译)
Nature. 2003 Jul 3;424(6944):21-2. doi: 10.1038/424021a.
4
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.人类载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)抗逆转录病毒酶中的单个氨基酸取代赋予了对HIV-1病毒体感染性因子诱导的耗竭的抗性。
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. doi: 10.1073/pnas.0400830101. Epub 2004 Mar 30.
5
[The innate antiretroviral defense of human cells, based on the DNA editing].[基于DNA编辑的人类细胞先天性抗逆转录病毒防御]
Postepy Biochem. 2006;52(3):247-52.
6
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.一种抑制HIV-1感染且被病毒Vif蛋白抑制的人类基因的分离。
Nature. 2002 Aug 8;418(6898):646-50. doi: 10.1038/nature00939. Epub 2002 Jul 14.
7
Death by deamination: a novel host restriction system for HIV-1.脱氨基作用导致的死亡:一种针对HIV-1的新型宿主限制系统。
Cell. 2003 Aug 8;114(3):281-3. doi: 10.1016/s0092-8674(03)00602-0.
8
Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.灵长类慢病毒Vif和蛋白酶体抑制剂对1型人类免疫缺陷病毒APOBEC3G病毒体包装的影响。
J Virol. 2004 Feb;78(4):2072-81. doi: 10.1128/jvi.78.4.2072-2081.2004.
9
New insights into the role of Vif in HIV-1 replication.对Vif在HIV-1复制中作用的新见解。
AIDS Rev. 2004 Jan-Mar;6(1):34-9.
10
APOBEC3G targets human T-cell leukemia virus type 1.载脂蛋白B mRNA编辑酶催化多肽样蛋白3G靶向1型人类T细胞白血病病毒。
Retrovirology. 2005 May 19;2:32. doi: 10.1186/1742-4690-2-32.

引用本文的文献

1
HIV-1 vif mediates ubiquitination of the proximal protomer in the APOBEC3H dimer to induce degradation.HIV-1病毒感染因子介导载脂蛋白B mRNA编辑酶催化多肽样蛋白3H二聚体中近端原体的泛素化,以诱导其降解。
Nat Commun. 2025 Jul 1;16(1):5879. doi: 10.1038/s41467-025-60984-y.
2
Overview of host-directed antiviral targets for future research and drug development.未来研究和药物开发的宿主导向抗病毒靶点概述。
Acta Pharm Sin B. 2025 Apr;15(4):1723-1751. doi: 10.1016/j.apsb.2025.03.011. Epub 2025 Mar 8.
3
Design and Characterization of Inhibitors of Cell-Mediated Degradation of APOBEC3G That Decrease HIV-1 Infectivity.

本文引用的文献

1
Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.1型人类免疫缺陷病毒的病毒感染因子(Vif)在活跃感染而非慢性感染期间能有效地包装进病毒粒子中。
J Virol. 2003 Jan;77(2):1131-40. doi: 10.1128/jvi.77.2.1131-1140.2003.
2
RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators.RNA编辑酶载脂蛋白B mRNA编辑酶1(APOBEC1)及其一些同源物可充当DNA突变因子。
Mol Cell. 2002 Nov;10(5):1247-53. doi: 10.1016/s1097-2765(02)00742-6.
3
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
降低HIV-1感染性的APOBEC3G细胞介导降解抑制剂的设计与表征
Viruses. 2025 Apr 1;17(4):514. doi: 10.3390/v17040514.
4
DHX15 inhibits mouse APOBEC3 deamination.DHX15抑制小鼠载脂蛋白B编辑酶催化多肽3脱氨基作用。
PLoS Pathog. 2025 Apr 1;21(4):e1013045. doi: 10.1371/journal.ppat.1013045. eCollection 2025 Apr.
5
Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging.使用双报告基因传感器细胞和活细胞成像对菌株特异性HIV-1 Vif活性进行单细胞描绘。
J Virol. 2025 Mar 18;99(3):e0157924. doi: 10.1128/jvi.01579-24. Epub 2025 Feb 25.
6
HIV-1 Vif global diversity and possible APOBEC-mediated response since 1980.自1980年以来的HIV-1 Vif全球多样性及可能的载脂蛋白B mRNA编辑酶催化多肽样蛋白介导的反应
Virus Evol. 2024 Dec 12;11(1):veae108. doi: 10.1093/ve/veae108. eCollection 2025.
7
An overview of the functions and mechanisms of APOBEC3A in tumorigenesis.载脂蛋白B编辑酶催化多肽样3A(APOBEC3A)在肿瘤发生中的功能及机制概述。
Acta Pharm Sin B. 2024 Nov;14(11):4637-4648. doi: 10.1016/j.apsb.2024.08.020. Epub 2024 Aug 27.
8
C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic.新冠病毒中C到U的转换偏好:自新冠疫情开始4年后仍然猖獗。
mBio. 2024 Dec 11;15(12):e0249324. doi: 10.1128/mbio.02493-24. Epub 2024 Oct 30.
9
Molecular mechanism for regulating APOBEC3G DNA editing function by the non-catalytic domain.非催化结构域调控 APOBEC3G DNA 编辑功能的分子机制
Nat Commun. 2024 Oct 10;15(1):8773. doi: 10.1038/s41467-024-52671-1.
10
Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain.Apobec 介导的逆转录病毒体内超突变依赖于小鼠品系。
PLoS Pathog. 2024 Aug 29;20(8):e1012505. doi: 10.1371/journal.ppat.1012505. eCollection 2024 Aug.
一种抑制HIV-1感染且被病毒Vif蛋白抑制的人类基因的分离。
Nature. 2002 Aug 8;418(6898):646-50. doi: 10.1038/nature00939. Epub 2002 Jul 14.
4
AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.活化诱导胞嘧啶脱氨酶使大肠杆菌发生突变,提示抗体多样化存在DNA脱氨基机制。
Nature. 2002 Jul 4;418(6893):99-103. doi: 10.1038/nature00862.
5
Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome.在一株完整的人类免疫缺陷病毒1型沃(Vau)O组基因组逆转录过程中持续发生的G→A超突变。
J Gen Virol. 2002 Apr;83(Pt 4):801-805. doi: 10.1099/0022-1317-83-4-801.
6
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.位于22号染色体上的灵长类动物特有的孤儿C到U RNA编辑酶基因座。
Genomics. 2002 Mar;79(3):285-96. doi: 10.1006/geno.2002.6718.
7
Antiviral actions of interferons.干扰素的抗病毒作用。
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents. doi: 10.1128/CMR.14.4.778-809.2001.
8
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells.因超突变而发生基因损伤的1型人类免疫缺陷病毒DNA序列,在患者外周血单个核细胞中通常大量存在,且可能在CD4(+) T细胞近乎同时受到感染和激活的过程中产生。
J Virol. 2001 Sep;75(17):7973-86. doi: 10.1128/jvi.75.17.7973-7986.2001.
9
Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.1型人类免疫缺陷病毒的Vif蛋白通过与病毒基因组RNA相互作用而被包装进核蛋白复合体中。
J Virol. 2001 Aug;75(16):7252-65. doi: 10.1128/JVI.75.16.7252-7265.2001.
10
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.RNA编辑:载脂蛋白B信使核糖核酸中胞嘧啶向尿嘧啶的转化
Biochim Biophys Acta. 2000 Nov 15;1494(1-2):1-13. doi: 10.1016/s0167-4781(00)00219-0.